-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic Heart Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ninerafaxstat in Coronary Artery Disease (CAD)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol Isolate in Menstrual Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cannabidiol Isolate in Menstrual Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cannabidiol Isolate in Menstrual Disorders Drug Details: Cannabidiol isolate is under...
-
Product Insights
NewAutism Spectrum Disorder (ASD) – Drugs In Development, 2024
Empower your strategies with our Autism Spectrum Disorder (ASD) – Drugs In Development, 2024 report and make more profitable business decisions. Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social interaction, communication, and repetitive behaviors. Symptoms range from mild to severe, forming a spectrum. Individuals with ASD may have difficulties in understanding social cues, expressing emotions, and engaging in reciprocal conversations. Sensory sensitivities are common, affecting responses to stimuli. Early intervention and tailored support can enhance communication...
-
Product Insights
NewPanic Disorders – Drugs In Development, 2024
Empower your strategies with our Panic Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Panic disorder is an anxiety disorder characterized by regular, sudden attacks of fear. Patients with this disorder have feelings of anxiety, stress, and panic regularly and at any time, often for no apparent reason. Symptoms may include a racing heartbeat, feeling faint, sweating, nausea, and chest pain. The Panic Disorders drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol 2 in Autism Spectrum Disorder (ASD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol 2 in Autism Spectrum Disorder (ASD) Drug Details:Cannabidiol is under development for the treatment of pervasive...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RMC-6236 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RMC-6236 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RMC-6236 in Colorectal Cancer Drug Details:RMC-6236 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol Isolate in Menstrual Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol Isolate in Menstrual Disorders Drug Details:Cannabidiol isolate is under development for the treatment of menstrual-related symptoms....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AB-1005 in Multiple...
-
Company Insights
Innovation and Patenting activity of Canopy Growth Corp Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Canopy Growth Corp Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Profile
Canopy Growth Corp – Company Profile
Canopy Growth Corp (Canopy Growth), a subsidiary of Constellation Brands Inc, is a cannabis company that carries the production, distribution and marketing of a range of cannabis and hemp-based products for medical and recreational businesses. The company offers cannabis products including curated cannabis varieties including soft gel capsules, dried cannabis flowers, vapes, and edibles. beverages, oils and concentrates and cannabis accessories. Canopy Growth also provides hemp-derived CBD products such as topical creams, oils and soft gels and nutrition beverages. The...
Add to Basket